Founded in January 2024 following the approval of a key patent, VerTan Technologies builds on pioneering research in nanoparticle technology. Originally focused on antimicrobial properties of silver nanoparticles, our co-founders expanded the technology’s applications to include cancer therapies and cosmetics. They developed a method to combine different noble metals into single nanoparticles, achieving enhanced effects with biologically active coatings.

To further harness the potential of these nanoparticle formulations, we developed EurekaAI, an advanced predictive platform designed to identify new applications and optimal formulations from our patented pool, significantly reducing R&D costs and time.

EurekaAI has already predicted several potent formulations for anti-aging and anti-inflammatory cosmetics, which will be marketed in partnership with a company specializing in laser cosmetic devices, providing early-stage revenue. Future development stages will target the agriculture and veterinary sectors, as identified by EurekaAI.